These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11104578)

  • 1. Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors.
    Ferlini C; Distefano M; Pignatelli F; Lin S; Riva A; Bombardelli E; Mancuso S; Ojima I; Scambia G
    Br J Cancer; 2000 Dec; 83(12):1762-8. PubMed ID: 11104578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer.
    Gallo D; Ferlini C; Distefano M; Cantelmo F; Gaggini C; Fattorossi A; Riva A; Bombardelli E; Proietti E; Mancuso S; Scambia G
    Cancer Chemother Pharmacol; 2000; 45(2):127-32. PubMed ID: 10663627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis.
    Jordan MA; Ojima I; Rosas F; Distefano M; Wilson L; Scambia G; Ferlini C
    Chem Biol; 2002 Jan; 9(1):93-101. PubMed ID: 11841942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal chemistry and chemical biology of new generation taxane antitumor agents.
    Ojima I; Geney R; Ungureanu IM; Li D
    IUBMB Life; 2002; 53(4-5):269-74. PubMed ID: 12121008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
    Cai P; Lu P; Sharom FJ; Fang WS
    Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effects toward human hematopoietic progenitor cells and tumor cell lines of paclitaxel, docetaxel, and newly developed analogues IDN5109, IDN5111, and IDN5127.
    Ferlini C; Distefano M; Pierelli L; Bonanno G; Riva A; Bombardelli E; Ojima I; Mancuso S; Scambia G
    Oncol Res; 1999; 11(10):471-8. PubMed ID: 10850888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
    Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
    Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
    Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming multidrug resistance in taxane chemotherapy.
    Geney R; Ungureanu lM; Li D; Ojima I
    Clin Chem Lab Med; 2002 Sep; 40(9):918-25. PubMed ID: 12435109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.
    Taraboletti G; Micheletti G; Rieppi M; Poli M; Turatto M; Rossi C; Borsotti P; Roccabianca P; Scanziani E; Nicoletti MI; Bombardelli E; Morazzoni P; Riva A; Giavazzi R
    Clin Cancer Res; 2002 Apr; 8(4):1182-8. PubMed ID: 11948131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer.
    Cassinelli G; Lanzi C; Supino R; Pratesi G; Zuco V; Laccabue D; Cuccuru G; Bombardelli E; Zunino F
    Clin Cancer Res; 2002 Aug; 8(8):2647-54. PubMed ID: 12171897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
    Vredenburg MR; Ojima I; Veith J; Pera P; Kee K; Cabral F; Sharma A; Kanter P; Greco WR; Bernacki RJ
    J Natl Cancer Inst; 2001 Aug; 93(16):1234-45. PubMed ID: 11504769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models.
    Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells.
    Distefano M; Scambia G; Ferlini C; Gaggini C; De Vincenzo R; Riva A; Bombardelli E; Ojima I; Fattorossi A; Panici PB; Mancuso S
    Int J Cancer; 1997 Sep; 72(5):844-50. PubMed ID: 9311603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses and biological activity of C-3'-difluoromethyl-taxoids.
    Ojima I; Lin S; Slater JC; Wang T; Pera P; Bernacki RJ; Ferlini C; Scambia G
    Bioorg Med Chem; 2000 Jul; 8(7):1619-28. PubMed ID: 10976509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.
    Kovár J; Ehrlichová M; Smejkalová B; Zanardi I; Ojima I; Gut I
    Anticancer Res; 2009 Aug; 29(8):2951-60. PubMed ID: 19661300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities.
    Ali S; Ahmad I; Peters A; Masters G; Minchey S; Janoff A; Mayhew E
    Anticancer Drugs; 2001 Feb; 12(2):117-28. PubMed ID: 11261884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on biological activity of certain microtubule-interacting taxanes.
    Miglietta A; Bocca C; Gabriel L
    Chem Biol Interact; 2002 Mar; 139(3):283-99. PubMed ID: 11879817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis.
    Ferlini C; Scambia G; Distefano M; Filippini P; Isola G; Riva A; Bombardelli E; Fattorossi A; Benedetti Panici P; Mancuso S
    Br J Cancer; 1997; 75(6):884-91. PubMed ID: 9062411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies to overcome taxane resistance in cancer.
    Das T; Anand U; Pandey SK; Ashby CR; Assaraf YG; Chen ZS; Dey A
    Drug Resist Updat; 2021 Mar; 55():100754. PubMed ID: 33691261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.